Rockwell Medical, Inc. RMTI

Full chart Compare
Set alert

Price alert · RMTI

All alert types
8.05 USD -0.04 (-0.49%)

At closeNov 4, 2026, 4:27 PM EST

8.05 0.00 0.00%

After hours · Nov 4, 4:27 PM ET

7.83 Day range 8.39
4.89 52-week range 12.90
YTD
-3.01%
1 year
-22.60%

Financial health

Altman Z-Score

-7.62 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 5

Valuation

P/E -5.6×
FY 2016: -16.8×FY 2017: -11.4×FY 2018: -3.7×FY 2019: -4.8×FY 2020: -2.5×FY 2021: -1.2×FY 2022: -0.5×FY 2023: -5.2×FY 2024: -81.6×FY 2025: -5.6×
FY 2016 5y median -5.2× FY 2025
P/S 0.4×
FY 2016: 6.2×FY 2017: 5.2×FY 2018: 1.9×FY 2019: 2.4×FY 2020: 1.2×FY 2021: 0.6×FY 2022: 0.1×FY 2023: 0.5×FY 2024: 0.6×FY 2025: 0.4×
FY 2016 5y median 0.5× FY 2025
P/B 0.8×
FY 2016: 6.3×FY 2017: 9.0×FY 2018: 4.4×FY 2019: 7.3×FY 2020: 2.2×FY 2021: 15.2×FY 2022: 0.7×FY 2023: 2.1×FY 2024: 1.9×FY 2025: 0.8×
FY 2016 5y median 1.9× FY 2025
P/FCF -25.0×
FY 2016: -25.9×FY 2017: -13.0×FY 2018: -5.6×FY 2019: -5.2×FY 2020: -2.5×FY 2021: -1.1×FY 2022: -0.6×FY 2023: -4.5×FY 2024: 19.9×FY 2025: -25.0×
FY 2016 5y median -1.1× FY 2025
EV/EBITDA -15.9×
FY 2016: -16.9×FY 2017: -11.3×FY 2018: -3.1×FY 2019: -4.5×FY 2020: -1.9×FY 2021: -1.9×FY 2022: -1.0×FY 2023: -10.3×FY 2024: 20.7×FY 2025: -15.9×
FY 2016 5y median -1.9× FY 2025
EV/Sales 0.5×
FY 2016: 5.9×FY 2017: 5.0×FY 2018: 1.5×FY 2019: 2.3×FY 2020: 0.8×FY 2021: 0.9×FY 2022: 0.2×FY 2023: 0.6×FY 2024: 0.6×FY 2025: 0.5×
FY 2016 5y median 0.6× FY 2025
FCF Yield -4.0%
FY 2016: -3.9%FY 2017: -7.7%FY 2018: -17.9%FY 2019: -19.2%FY 2020: -40.2%FY 2021: -88.6%FY 2022: -172.7%FY 2023: -22.0%FY 2024: 5.0%FY 2025: -4.0%
FY 2016 5y median -22.0% FY 2025

Profitability

Gross Margin 16.9%
FY 2016: 12.7%FY 2017: 6.5%FY 2018: -2.5%FY 2019: 4.6%FY 2020: 4.4%FY 2021: -3.9%FY 2022: 5.6%FY 2023: 10.4%FY 2024: 17.2%FY 2025: 16.9%
FY 2016 5y median 10.4% FY 2025
Operating Margin -6.8%
FY 2016: -37.9%FY 2017: -45.2%FY 2018: -51.2%FY 2019: -55.6%FY 2020: -45.7%FY 2021: -49.0%FY 2022: -23.0%FY 2023: -8.0%FY 2024: 0.6%FY 2025: -6.8%
FY 2016 5y median -8.0% FY 2025
Net Margin -7.7%
FY 2016: -37.2%FY 2017: -45.2%FY 2018: -50.7%FY 2019: -55.7%FY 2020: -49.7%FY 2021: -52.8%FY 2022: -25.7%FY 2023: -10.1%FY 2024: -0.5%FY 2025: -7.7%
FY 2016 5y median -10.1% FY 2025
ROE -14.4%
FY 2016: -37.4%FY 2017: -78.8%FY 2018: -117.8%FY 2019: -168.0%FY 2020: -90.4%FY 2021: -1288.9%FY 2022: -132.4%FY 2023: -39.6%FY 2024: -1.5%FY 2025: -14.4%
FY 2016 5y median -39.6% FY 2025
ROIC -9.5%
FY 2016: -27.7%FY 2017: -52.2%FY 2018: -82.4%FY 2019: -91.5%FY 2020: -43.0%FY 2021: -81.0%FY 2022: -50.7%FY 2023: -17.7%FY 2024: 1.3%FY 2025: -9.5%
FY 2016 5y median -17.7% FY 2025
ROA -9.3%
FY 2016: -23.8%FY 2017: -44.1%FY 2018: -61.1%FY 2019: -77.0%FY 2020: -39.7%FY 2021: -67.3%FY 2022: -40.1%FY 2023: -16.2%FY 2024: -0.8%FY 2025: -9.3%
FY 2016 5y median -16.2% FY 2025

Growth (YoY)

Revenue -31.8%
FY 2016: -3.7%FY 2017: 7.5%FY 2018: 10.6%FY 2019: -3.3%FY 2020: 1.5%FY 2021: -0.4%FY 2022: 17.6%FY 2023: 14.8%FY 2024: 21.4%FY 2025: -31.8%
FY 2016 FY 2025
Operating Income -871.5%
FY 2016: -33.8%FY 2017: -28.3%FY 2018: -25.1%FY 2019: -5.1%FY 2020: 16.6%FY 2021: -6.7%FY 2022: 44.7%FY 2023: 60.3%FY 2024: 109.1%FY 2025: -871.5%
FY 2016 FY 2025
EPS (diluted) -500.0%
FY 2016: -34.5%FY 2017: -30.8%FY 2018: -19.3%FY 2019: 16.1%FY 2020: 20.0%FY 2021: 14.7%FY 2022: 50.7%FY 2023: 81.0%FY 2024: 93.1%FY 2025: -500.0%
FY 2016 FY 2025
Free Cash Flow -137.6%
FY 2016: 24.9%FY 2017: -78.0%FY 2018: 6.1%FY 2019: -33.5%FY 2020: -7.3%FY 2021: -11.0%FY 2022: 49.5%FY 2023: 43.7%FY 2024: 132.9%FY 2025: -137.6%
FY 2016 FY 2025

Financial Health

Current Ratio 4.0×
FY 2016: 7.7×FY 2017: 5.3×FY 2018: 3.5×FY 2019: 3.0×FY 2020: 5.4×FY 2021: 1.7×FY 2022: 2.0×FY 2023: 1.7×FY 2024: 2.6×FY 2025: 4.0×
FY 2016 5y median 2.0× FY 2025
Quick Ratio 3.6×
FY 2016: 6.5×FY 2017: 4.5×FY 2018: 3.2×FY 2019: 2.7×FY 2020: 5.1×FY 2021: 1.5×FY 2022: 1.7×FY 2023: 1.4×FY 2024: 2.2×FY 2025: 3.6×
FY 2016 5y median 1.7× FY 2025
Debt / Equity 0.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.2×FY 2020: 0.7×FY 2021: 11.4×FY 2022: 1.2×FY 2023: 0.6×FY 2024: 0.4×FY 2025: 0.3×
FY 2016 5y median 0.6× FY 2025
Net Debt / EBITDA -0.9×
FY 2016: 0.9×FY 2017: 0.3×FY 2018: 0.7×FY 2019: 0.2×FY 2020: 0.9×FY 2021: -0.6×FY 2022: -0.4×FY 2023: -0.9×FY 2024: -0.7×FY 2025: -0.9×
FY 2016 5y median -0.7× FY 2025
Interest Coverage -4.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -15.1×FY 2021: -12.9×FY 2022: -8.7×FY 2023: -2.9×FY 2024: 0.5×FY 2025: -4.2×
FY 2016 5y median -4.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31